05.11.2025 • NewsAsahi KaseiBatterieselectrolytes

Asahi Kasei Licenses Novel Electrolyte Technology to EAS Batteries

Global manufacturer Asahi Kasei and German battery manufacturer EAS Batteries signed a license agreement for the use of Asahi Kasei's acetonitrile-containing electrolyte technology.

The electrolyte will be used in EAS' novel ultra-high power lithium-ion battery cell using lithium iron phosphate (LFP) cathode. The electrolyte's high ionic conductivity contributes to reduced internal cell resistance and enhanced rate capability, even under demanding temperature conditions. The market launch of EAS Batteries’ new cell utilizing this technology is in line with Asahi Kasei’s commercialization plans, with the product scheduled to be released no later than March 2026.

The development of the new cylindrical, ultra-high-power cell, is based on a collaboration between Asahi Kasei and EAS Batteries, with financial support from Germany’s Federal Ministry of Research, Technology, and Space under the “HEADLINE” project. Under this collaboration, Asahi Kasei designed its electrolyte technology to target demanding applications in marine, railway, and construction machinery. This innovative breakthrough was made possible by leveraging the company's expertise with over three decades of lithium-ion cell research and development.

In 2010, Asahi Kasei began developing a high ionic conductive electrolyte, with Honorary Fellow Akira Yoshino focusing on acetonitrile as a promising ingredient in lithium-ion battery electrolytes. In June 2024, the company announced the successful proof of concept for lithium-ion batteries using its proprietary high ionic conductive electrolyte containing acetonitrile. This technological breakthrough enables increased power output at low temperatures and improved durability at high temperatures.

Designed to meet the rigorous requirements of the mobility, industrial, and aerospace sectors, the new cell demonstrates a specific power approximately 60% higher than that of cells using conventional electrolytes. The reduced internal resistance of the new cell also results in lower heat generation during cycling and improved energy efficiency compared to cells using conventional electrolytes.

EAS ultra-high-power lithium-ion cell.
EAS ultra-high-power lithium-ion cell.
© Asahi Kasei

Asahi Kasei and EAS Batteries have agreed to sublicense their combined technologies to global OEMs and battery manufacturers, aiming to expand into mobility applications.

Michael Deutmeyer, Managing Director of EAS Batteries, comments on the collaboration: “Our collaboration with Asahi Kasei sets a strong foundation for advancing cell quality and performance, especially for high-power cells. The robustness of the electrolyte is key—not only for EAS products but also for scaling our technology across markets. Strategic partnerships like this enable tailored solutions for future demands.”

“We are proud to provide high ionic conductivity electrolyte technology that contributes to battery cells which set a new benchmark for high power output,” said Osamu Matsuzaki, Senior Executive Officer of Asahi Kasei and Head of Corporate R&D and IP. “By combining our technology with the expertise of EAS, we achieved an advanced cell design with unprecedented performance. As energy systems transform worldwide, I am confident that our technology will enable the further development of high-performance cells with clear competitive advantage.”

Company

Logo:

Asahi Kasei Europe

Fringsstraße 17
40221 Düsseldorf
Germany

Company contact







Virtual Event

Downstream Purification
Bioprocess Forum

Downstream Purification

Save the Date: November 21+25, 2025
Join leading scientists, process engineers, and biomanufacturing innovators for a two-day virtual event exploring the latest breakthroughs in downstream purification.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read